Press review


Spanish medical societies propose amendments to draft law that could limit use of patient data

Country : Germany, Spain, U.S.

Keywords :
MADRID, Jan 26 (APM) - The Spanish Federation of Scientific and Medical Associations (FACME) plans to propose modifications to a draft data protection law which would limit the use of patients’ data for research purposes, financial El Economista, medical journals El Médico Interactivo, Redacción Médica, Acta Sanitaria and Gaceta Médica report on Friday.
FACME president Francisco Carballo had said Spain’s planned data protection law would seriously affect research. (APMHE 56394)
He said Spanish law should be in accordance with EU directives, which allow data to be treated as exemptions when they are going to be used for the good of the community, which is “clearly” the case with medical research, El Economista reports.
Carballo said that Germany’s new data protection law specifically refers to medical research, guaranteeing good medical practice and improving public healthcare, El Economista adds.
FACME representatives have expressed concern about the need to obtain patients’ explicit consent to their data being reused, even when they have already given permission for researchers to use it for research purposes, Gaceta Médica says.
The journal quoted Carballo as saying that reusing and analysing patients’ data is key to obtain medical evidence of healthcare outcomes and improve the quality of the healthcare system.
In a separate Friday story, El Economista reports that the Spanish data protection agency has warned the new law will be enforced as of May, with no adaptation time after that.

Best-paid executive in Germany is a Spanish woman

Belén Garijo, Merck KGaA’s pharma head, is the best-paid executive in Germany according to the country’s financial journal Handelsblatt, dailies ABC, La Razón and La Vanguardia reported on Saturday. A number of regional newspapers carried the story at the weekend.
According to Handelsblatt, Garijo earned 5.7 million euros in 2017. She runs a group with over 7 billion euros in sales and has over 20,000 employees. She joined the firm’s board of directors in January 2015, la Vanguardia reported.
She had previously worked for Aventis and Rhône-Poulenc Rorer, the newspaper noted.

Russia’s Kraspharma to invest in Andalusia

Kraspharma plans to open a manufacturing plant in Cordoba, Andalusia, dailies ABC, 20 Minutos, La Vanguardia, financial El Economista and a number of regional newspapers reported on Thursday.
According to ABC, the firm will invest 26 million euros in the construction site over the next few months. The plant will be devoted to manufacturing cancer drugs, with 120 employees among whom about 60 will be highly qualified. It will be operational in 2019, it added.

Merck & Co 'most admired' pharma because of innovation initiatives

Merck & Co's capacity for innovation has made it the highest-ranking pharmaceutical firm in the ‘World’s Most Admired Companies’ list published by Fortune magazine, financial El Economista and medical journal Redacción Médica reported on Thursday.
Around 3,900 executives, analysts and experts voted for the most admired companies in nine categories including innovation, value of investment, management quality and capacity to attract talent, El Economista noted.

AstraZeneca among 100 'most sustainable' companies

Canadian investment consulting group Corporate Knights has included AstraZeneca in its ranking of the 100 most sustainable companies in the world, financial El Economista, medical journals Redacción Médica and Acta Sanitaria report on Friday.
The company has also been praised in the latest report by The Climate Group, published in Davos, because of its use of renewables, Acta Sanitaria reported.

Former Lilly executive appointed U.S. secretary of health

Alex Azar, former head of operations for Eli Lilly in the U.S., has been appointed the next secretary of health and human services, medical journal Redacción Médica reports on Friday.
The U.S. senate confirmed Mr. Azar’s nomination. He had previously been deputy secretary of health and human services under president George Bush, the journal adds.



Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations

Events coverage with a unique focus on Market Access & sustainability of healthcare systems

6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris

Ask for a Free trial and get access to our last stories

Request a trial to assess coverage that includes:
  • Health Care
  • Market Access
  • HTA – policies & practices
  • European medicine regulations
  • Drug safety issues
  • Pricing & Reimbursement
  • International medicines agencies

If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.


an initial 10 day temporary access of APM Health Europe.